← Back to All Filings

HCA Healthcare CEO Exercises Options, Sells $13M in Stock for Taxes

Low SignificanceNovember 4, 2025 at 6:32:49 PM EST

HCA Healthcare, Inc.

$HCA4CIK: 0000860730

Subscribe to track HCA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

HCA Healthcare CEO Exercises Options, Sells $13M in Stock for Taxes

Company: HCA Healthcare, Inc. (HCA) Form: 4 | Filed: 2025-11-04 Significance: Low

Insider: HAZEN SAMUEL N Title: CEO | Relationship: Director, Officer

Transaction: • Type: Sell to Cover Taxes (Code F) • Shares: 28,173 • Price: $459.68 • Value: $12,950,836 • Owned After (Total): 1,363,513

Key Insight: The CEO exercised stock appreciation rights and automatically sold shares to cover the associated costs and tax liability. This is a routine, non-discretionary transaction related to compensation and does not signal a change in outlook.

Market Context: The $13M sale represents only 0.012% of HCA's $104.9B market cap, making it immaterial from a market perspective.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: HCA Healthcare, Inc. (HCA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The CEO of HCA Healthcare conducted a routine, non-discretionary "sell-to-cover" transaction to pay for the exercise of stock appreciation rights, a common practice related to executive compensation.
  • Market Impact: The transaction is considered immaterial, representing a negligible fraction of the company's market capitalization and shares outstanding.

Company Information

FieldValue
CompanyHCA Healthcare, Inc.
Ticker SymbolHCA
CIK0000860730
IndustryGeneral Medical & Surgical Hospitals

Insider Information

FieldValue
NameHAZEN SAMUEL N
CIK0001216838
Title/PositionCEO
RelationshipDirector, Officer

Transaction Details

This filing reports two key transactions: an exercise of derivative securities and a subsequent disposition to cover costs.

1. Derivative Exercise (Code 'M')

  • Action: Exercised 58,050 Stock Appreciation Rights (SARs) to acquire 58,050 shares of Common Stock.
  • Exercise Price: $69.58 per share.

2. Stock Disposition (Code 'F')

  • Action: Disposed of 28,173 shares of Common Stock to cover the exercise price and tax liabilities.
  • Price Per Share: $459.68
  • Total Value: $12,950,836
  • Shares Owned After (Direct): 47,106
  • Shares Owned After (Total): 1,363,513 (including indirect holdings)

Financial Impact Assessment

Transaction Materiality

The analysis focuses on the $13M disposition, as it represents the largest value component.

MetricValue
Transaction Value$12,950,836
% of Market Cap0.012%
Shares Transacted28,173
% of Shares Outstanding0.012%
Post-Transaction Ownership1,363,513 shares (0.58% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap company like HCA with a market capitalization of $104.9 billion, a $13 million transaction is financially insignificant.
  • Ownership Concentration: The CEO's total ownership of 0.58% post-transaction is substantial but did not materially change as a result of this compensation-related event.
  • Transaction Significance: The transaction's value and share count fall well below the thresholds for moderate or high significance (<0.1% of market cap and <0.1% of shares outstanding). The 'F' code confirms its non-discretionary nature, reducing its signaling value to near zero.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a pre-planned or automatic sale to cover costs associated with vested equity awards. It is not an open-market sale reflecting the insider's sentiment on the stock's future performance.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is too small relative to the stock's typical daily trading volume to have a noticeable effect.
  • Sentiment Indicator: Neutral. The market generally understands and disregards 'sell-to-cover' transactions as they are not indicative of an insider's investment thesis.

Additional Context

Transaction Notes

  • Nature of Transaction: This is a classic cashless exercise of stock appreciation rights. The insider acquires shares by exercising vested options/SARs and immediately sells a portion of those shares at the current market price to cover the cost of the exercise and the resulting tax bill. The net result was an increase of 29,877 shares to the CEO's direct holdings.
Topics:#HCA#HCAHealthcare#SECFiling#Form4#InsiderTrading#CEO#StockOptions#Healthcare#Investing#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.